topotecan has been researched along with arginine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chillemi, G; D'Annessa, I; Desideri, A; Fiorani, P; Tesauro, C; Turchi, G | 1 |
| Ghaemmaghami, M; Jett, JR | 1 |
| Bartussek, C; Naumann, U; Weller, M | 1 |
| Dichgans, J; Esser, P; Meyermann, R; Rieger, J; Rieger, L; Streffer, J; Weller, M; Winter, S | 1 |
| Furbee, CS; Muller, MT; Subramanian, D | 1 |
| Dingemans, AC; Giaccone, G; Postmus, PE; Scagliotti, GV; Span, S; van Ark-Otte, J; van der Valk, P | 1 |
| Beck, WT; Ee, PL; Mo, YY; Yu, Y | 1 |
| Cardona, AF; Reveiz, L; Rueda, JR | 1 |
3 review(s) available for topotecan and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New agents in the treatment of small cell lung cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Drugs, Investigational; Gemcitabine; Humans; Immunologic Factors; Irinotecan; Lung Neoplasms; Menogaril; Paclitaxel; Taxoids; Teniposide; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Chemotherapy for brain metastases from small cell lung cancer.
Topics: Antineoplastic Agents; Brain Neoplasms; Cisplatin; Cranial Irradiation; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Teniposide; Topotecan | 2012 |
6 other study(ies) available for topotecan and arginine
| Article | Year |
|---|---|
Erybraedin C, a natural compound from the plant Bituminaria bituminosa, inhibits both the cleavage and religation activities of human topoisomerase I.
Topics: Arginine; Binding Sites; Catalysis; Catalytic Domain; DNA Topoisomerases, Type I; Enzyme Inhibitors; Fabaceae; Histidine; Humans; Models, Molecular; Plant Extracts; Protein Binding; Pterocarpans; Topoisomerase I Inhibitors; Topotecan; Tyrosine | 2010 |
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Carmustine; Cell Death; Cell Division; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioma; Humans; In Vitro Techniques; Paclitaxel; Point Mutation; Radiotherapy; Teniposide; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 1999 |
Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Carmustine; Combined Modality Therapy; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; In Vitro Techniques; Male; Middle Aged; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Topotecan; Tumor Cells, Cultured; Verapamil; Vincristine | 2000 |
ICE bioassay. Isolating in vivo complexes of enzyme to DNA.
Topics: Centrifugation, Density Gradient; Cesium; Chlorides; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Immunoblotting; Sarcosine; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 2001 |
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Topics: Amino Acid Substitution; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Isoenzymes; Ki-67 Antigen; Life Tables; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation, Missense; Neoplasm Proteins; Paclitaxel; Point Mutation; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Teniposide; Topotecan; Treatment Outcome; Vault Ribonucleoprotein Particles | 2001 |
Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Co-Repressor Proteins; Enzyme Inhibitors; Genes, Dominant; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Molecular Chaperones; Nuclear Proteins; Subcellular Fractions; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Ubiquitin-Conjugating Enzymes | 2004 |